Nov 09, 2025

I recently came across news of a bidding war between Novo and Pfizer for the takeover of Metsera, with Novo offering up to $10 billion and prompting Pfizer to increase their bid to $8.1 billion. The decision for Metsera will not only be based on the headline price but also on factors like Phase 2 clinical trials and potential antitrust issues.

Another notable development was the $500 million Series D funding raised by the tech-enabled parking lot network Metropolis, valuing the company at $5 billion. This funding will help enhance consumer convenience in parking and support their long-term investment in transportation automation.

Additionally, significant funding rounds were secured by companies like AAVantgarde Bio with $141 million in Series B funding and Neok Bio with $75 million in Series A funding, showcasing growth and innovation in the biotech and healthcare sectors.

Private equity deals and acquisitions also made headlines, including Bonaccord Capital Partners’ investment in Kingswood Capital Management and Comcast’s talks to acquire ITV’s media and entertainment division, highlighting the dynamic nature of the financial and investment landscape.

The news reflects ongoing activity and interest in various sectors, from biotech to private equity, with funding rounds, acquisitions, and partnerships driving growth and innovation. It will be interesting to see how these developments shape the future of these industries and the broader financial landscape.

Stay Well!